Other Industry News

VolitionRx Limited to Present at Multiple Investor Conferences in June

today announced it is scheduled to present at multiple investor conferences in June. Dr. Scott Powell, Executive Vice President of Volition, will provide an update on Volition's business, clinica... Full Story

China's Dahua Tech plans up to $1 billion Hong Kong share sale: sources

China's Zhejiang Dahua Technology Co Ltd (002236.SZ), a maker of security products, is planning to raise as much as $1 billion through a share offering in Hong Kong, three people with direct knowledg... Full Story

Janssen plans to expand pharma investment in China

Janssen, the pharmaceutical company, will expand its investment in China to drive growth as it races to seize more market shares in lung-related diseases. Part of the Johnson & Johnson group, Jans... Full Story

VoxelCloud, a California-China startup, Raises $10 Million for Medical Imaging AI

VoxelCloud, a Los Angeles-China medical artificial intelligence company, raised $10 million in a Series A round led by Sequoia Capital. Using AI and cloud computing, VoxelCloud plans to provide automated... Full Story

Chinese Pharmaceutical Firm GZ Bailing Group Pharm. Agrees to Back Herbal Medicine Maker

Chinese pharmaceutical firm GZ Bailing Group Pharm. Co. [SHE:002424] said in a statement that it will boost an herbal medicine company’s competitiveness by investing in it. The Anshun-based grou... Full Story

Celltrion Envisions Remsima Plant in China

Celltrion is set to move in to the Chinese market. Remsima, a biosimilar medicine effective for the treatment of patients with rheumatoid arthritis and ulcerative colitis. The company announced on May 24... Full Story

RepliCel CEO Provides Company Outlook

, a regenerative medicine company addressing large-market opportunities with innovative technologies in aesthetics and sports injury/orthopedics, today unveiled its go-forward strategy. In the first few m... Full Story

WuXi Biologics guns for $500M Hong Kong IPO

The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong. According to Thomson Reuters, quoting anonymous people "close to the deal,” the... Full Story

Chinese OEMs Qualify LFS Scintillation Crystals for use in Positron Emission Tomography Medical Scanning Devices

, a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that two additional Chinese, tier 1 positron emission tomography (PET) OEM integ... Full Story

Frontline BioVentures, WuXi Healthcare To Merge, Creating $800M Fund

Two Chinese venture firms, Frontline BioVentures and WuXi Healthcare Ventures, have agreed to merge to form one healthcare investment group named 6 Dimensions Capital, in a rare case of two venture firms... Full Story

Company Search

Upcoming Events More